MARKET

ACRS

ACRS

Aclaris Therapeutics Inc
NASDAQ
8.90
+0.20
+2.30%
Opening 11:09 06/02 EDT
OPEN
8.80
PREV CLOSE
8.70
HIGH
8.90
LOW
8.43
VOLUME
205.84K
TURNOVER
1.34M
52 WEEK HIGH
18.96
52 WEEK LOW
5.77
MARKET CAP
629.05M
P/E (TTM)
-6.1562
1D
5D
1M
3M
1Y
5Y
Peter Kolchinsky-led RA Capital’s New Positions Feature CureVac, Mineralys, Pilant, Enliven Therapeutics
NASDAQ · 05/23 08:29
Top Pharmaceutical Stocks for Q2 2023
Investopedia · 05/18 17:50
Stifel Nicolaus Reaffirms Their Buy Rating on Aclaris Therapeutics (ACRS)
TipRanks · 05/17 02:07
Aclaris Therapeutics (ACRS) Receives a Rating Update from a Top Analyst
TipRanks · 05/11 16:46
H.C. Wainwright Keeps Their Buy Rating on Aclaris Therapeutics (ACRS)
TipRanks · 05/10 10:35
Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), Annexon Biosciences (ANNX) and Immunocore Holdings (IMCR)
TipRanks · 05/09 10:10
Analysts Offer Insights on Healthcare Companies: NanoString Tech (NSTG), Aclaris Therapeutics (ACRS) and Surface Oncology (SURF)
TipRanks · 05/08 16:10
BRIEF-Aclaris Therapeutics Reports Q1 2023 Financial Results And Provides A Corporate Update
Reuters · 05/08 14:42
More
About ACRS
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a pipeline of drug candidates to address the needs of patients with immuno-inflammatory diseases. The Company has a multi-stage portfolio of drug candidates powered by a robust research and development (R&D) engine exploring protein kinase regulation. The Company operates through two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment includes provision of laboratory services. The Company is also engaged in identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize its novel drug candidates.

Webull offers kinds of Aclaris Therapeutics Inc stock information, including NASDAQ:ACRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACRS stock methods without spending real money on the virtual paper trading platform.